ascendis pharma glp-1 receptor agonists weight management diabetes treatments single, dual, and triple for treating type 2 and obesity: a narrative review Pharmacology Consult: GLP-1 receptor agonists

Patients struggling with cravings or addictive behaviors alongside weight or metabolic issues may benefit from discussing GLP-1 medications as part of their treatment plan

Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk

Clinically, these findings should be considered when treating patients with DPP-4i, especially in those patients with HF

Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects

View here - Our collaborative interpretation of Section 8.134 is that verification of sterility assurance is met by supplier qualification and evidence of sterilization on each unit received